Exosome Diagnostics and Treatment Market to Grow at a CAGR of 32.2% to reach US$ 358.91 Million from 2020 to 2027

Exosome Diagnostics and Therapeutic Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing & Targeted Sequencing, Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users)

Publication Month: Apr 2020 | Report Code: TIPRE00005514 | No. of Pages: 149 | Category: Biotechnology | Status: Published
Covid

The exosome diagnostic and therapeutic market was valued at US$ 41.6.33 million in 2019 and is expected to grow at a CAGR of 32.2% from 2020 to 2027 to reach US$ 358.91 million 2027.

 

Exosomes are nano-vesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication while diagnosing cancer. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T-cells, which modify neoplasm progression within the human body. The exosome diagnostic and therapeutic market is expected to witness huge growth due to greater precision and advantages over traditional methods of diagnosis and therapeutics. However, poor infrastructure and lack of expertise required for isolation of exosomes may hinder the market growth.

 

Lucrative Regions for Exosome Diagnostic and Therapeutic Market

Lucrative Regions for Exosome Diagnostic and Therapeutic Market

Get more information on this report :


 

Market Insights

Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics

Exosomes are distinct populations of tiny membranous vesicles, released into the extracellular space by most cells, which get eventually accumulated in the body fluid circulation. By acting as cellular messengers, they play a role in vital physiological functions by transporting information between different cell types. These tiny particles carry cellular nucleic acids and proteins from their host cells to target cells, which represent the comprehensive information about pathophysiological conditions of the host cell. For instance, exosomes released from tumor cells contains tumor-specific RNAs that can be potentially detected during cancer diagnosis. These carrier exosomes can also be used as biomarkers in the diagnosis of neurodegenerative and metabolic disorders, and infectious and other diseases. Additionally, the presence of exosomes in body fluids such as saliva and urine islikely to rule out the traditional methods involving the collection of the invasive body fluids.Thus, the growing emphasis on clinically noninvasive diagnosis is likely to drive the adoption of exosomes-based diagnosis and therapeutics in the medical industry during the forecast period.

 

Application-BasedInsights

Based on application, the exosome diagnostic and therapeutic market is further segmented into diagnostic applications and therapeutic applications. The diagnostic applications segment held a larger share of the market in 2019owing to increasing awareness of the procedural outcomes served by exosomes. For instance, in March 2016, Sysmex and JVCKENWOOD launched a joint program for the development of diagnostic instruments for measurement of exosomes. Also, the diagnostic segment is expected to register ahigher CAGR in the market during the forecast period. Apart from this, exosomes are emerging as promising therapeutic platforms due to its role in disease prorogation. Such involvement of exosomes can allow us to inhibit the disease progression with the help of targeted drug therapy.

 

Global Exosome Diagnostic and Therapeutic Market, by Application– 2019& 2027

Global Exosome Diagnostic and Therapeutic Market, by Application– 2019& 2027

Get more information on this report :


 

Product-BasedInsights

The exosome diagnostic and therapeuticmarket, by product, is sub segmented into instruments, reagents, and software.In 2019, the instrument segment accounted for the largest share of the global exosome diagnostic and therapeuticmarket owing to increasing adoption of instruments for diagnostic applications. However, the software segment is estimated to register the highest CAGR in the market during the forecast period. This can be attributed to the demand for technological platforms offering data integrity, access, and security for collected data in exosome diagnostic and therapeutic applications.

 

End User-BasedInsights

The exosome diagnostic and therapeutic market, by end user, is further segmented into cancer institute, hospitals, diagnostic centers, and others. The cancer institute segment held the largest share of the market in 2019 owing to increasing cancer cases and demand for advanced diagnostic approaches. Cancer instituteare specifically dedicated for the cancer research, drug development, and study on cancer management. The efficiency of exosomes in the diagnosis of cancer is projected to drive the growth of the cancer institute segment during the forecast period.

 

Strategic Insights

Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the exosome diagnostic and therapeuticmarketadopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

Exosome Diagnostic and Therapeutic Market – ByApplication

  • Diagnostic
  • Therapeutic


Exosome Diagnostic and Therapeutic Market – By Product

  • Instruments
  • Reagents
  • Software


Exosome Diagnostic and Therapeutic Market – By End User

  • Cancer Institutes
  • Hospitals
  • Diagnostic Centers
  • Others

 

Exosome Diagnostic and Therapeutic Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America (SAM)
    • Brazil
    • Argentina
    • Rest of SAM

 

Company Profiles

  • Aethlon Medical, Inc
  • Therapeutic Solutions International, Inc
  • ReNeuron Group plc
  • Immune Therapy Holdings AB
  • Cell Guidance Systems LLC
  • BioRegenerative Sciences
  • Evomic Science LLC
  • NorgenBiotek Corp
  • Exosome Diagnostics, Inc./Bio-Techne
  • MiltenyiBiotec

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Exosome diagnostic and therapeutic Market – By Application

1.3.2        Global Exosome diagnostic and therapeutic Market – By Product

1.3.3        Global Exosome diagnostic and therapeutic Market – By End User

1.3.4        Global Exosome Diagnostic and Therapeutic Market – By Geography

2.             Exosome Diagnostic And Therapeutic Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Exosome Diagnostic and Therapeutic Market – Market Landscape

4.1       Overview

4.2       Pest Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe– PEST Analysis

4.2.3        Asia Pacific– PEST Analysis

4.2.4        Middle East & Africa– PEST Analysis

4.2.5        South and Central America – PEST Analysis

5.             Global Exosome Diagnostic and Therapeutic Market – Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics

5.1.2        Rise in Research and Development Activities

5.2       Key Market Restraints

5.2.1        Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes

5.3       Key Market Opportunities

5.3.1        Growing Preference for Non-invasive and Novel Diagnostic Procedures

5.4       Future Trends

5.4.1        Automation of Exosome Isolation Process

5.5       Impact analysis

6.             Exosome Diagnostic and Therapeutic Market– Global Analysis

6.1       Global Exosome Diagnostic and Therapeutic Market Revenue Forecast And Analysis

6.2       Global Exosome Diagnostic and Therapeutic Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Exosome Diagnostic and Therapeutic Market Analysis – By Application

7.1       Overview

7.2       Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

7.3       Diagnostic

7.3.1        Overview

7.3.2        Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027  (US$ Thousand)

7.4       Therapeutic

7.4.1        Overview

7.4.2        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027  (US$ Thousand)

8.             Exosome Diagnostic and Therapeutic Market Analysis – By Product

8.1       Overview

8.2       Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)

8.3       Instruments

8.3.1        Overview

8.3.2        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

8.4       Reagents

8.4.1        Overview

8.4.2        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.5       Software

8.5.1        Overview

8.5.2        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9.             Exosome Diagnostic and Therapeutic Market Analysis – By End User

9.1       Overview

9.2       Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)

9.3       Cancer Institutes

9.3.1        Overview

9.3.2        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

9.4       Hospitals

9.4.1        Overview

9.4.2        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9.5       Diagnostic Centres

9.5.1        Overview

9.5.2        Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

9.6       Other End User

9.6.1        Overview

9.6.2        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

10.          Exosome Diagnostic and Therapeutic Market – Geographic Analysis

10.1    North America: Exosome Diagnostic and Therapeutic Market

10.1.1     Overview

10.1.2     North America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027  (USD Thousand)

10.1.3     North America: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027  (USD Thousands)

10.1.4     North America: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.5     North America: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.1.6     North America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

10.1.7     US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.7.1    US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.7.2    US: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.1.7.3    US: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.7.4    US: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.1.8     Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.8.1    Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.8.2    Canada: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.1.8.3    Canada: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.8.4    Canada: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.1.9     Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.9.1    Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.9.2    Mexico: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.1.9.3    Mexico: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.9.4    Mexico: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.2    Europe: Exosome Diagnostic and Therapeutic Market

10.2.1     Overview

10.2.2     Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)

10.2.3     Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)

10.2.4     Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.2.5     Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.2.6     Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

10.2.7     Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.7.1    Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.7.2    Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.2.7.3    Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.2.7.4    Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.2.8     France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.8.1    France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.8.2    France: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.2.8.3    France: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.2.8.4    France: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.2.9     UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.9.1    UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.9.2    UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.2.9.3    UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.2.9.4    UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.2.10   Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.10.1 Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.10.2 Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.2.10.3 Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.2.10.4 Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.2.11   Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.11.1 Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.2.11.2 Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.2.11.3 Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.2.11.4 Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.3    Asia Pacific: Exosome Diagnostic and Therapeutic Market

10.3.1     Overview

10.3.2     Asia Pacific: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027  (USD Thousand)

10.3.3     Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)

10.3.4     Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.3.5     Asia Pacific: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.3.6     Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

10.3.7     China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.7.1    China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.7.2    China: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.3.7.3    China: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.3.7.4    China: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.3.8     Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.8.1    Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.8.2    Japan: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.3.8.3    Japan: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.3.8.4    Japan: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.3.9     India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.9.1    India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.9.2    India: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.3.9.3    India: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.3.9.4    India: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.3.10   South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (USD Thousand)

10.3.10.1 South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.10.2 South Korea: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.3.10.3 South Korea: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.3.10.4 South Korea: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.3.11   Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.11.1 Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.3.11.2 Australia: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.3.11.3 Australia: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.3.11.4 Australia: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.4    Middle East and Africa: Exosome Diagnostic and Therapeutic Market

10.4.1     Overview

10.4.2     Middle East and Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)

10.4.3     Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)

10.4.4     Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027  (USD Thousand)

10.4.5     Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027  (USD Thousand)

10.4.6     Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

10.4.7     UAE: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.4.7.1    UAE: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.4.7.2    UAE: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.4.7.3    UAE: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.4.7.4    UAE: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.4.8     Saudi Arabia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (USD Thousand)

10.4.8.1    Saudi Arabia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.4.8.2    Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.4.8.3    Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.4.8.4    Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027  (USD Thousand)

10.4.9     South Africa: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (USD Thousand)

10.4.9.1    South Africa: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.4.9.2    South Africa: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.4.9.3    South Africa: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.4.9.4    South Africa: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.5    South and Central America: Exosome Diagnostic and Therapeutic Market

10.5.1     Overview

10.5.2     South and Central America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

10.5.3     South and Central America: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.5.4     South and Central America: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027  (USD Thousand)

10.5.5     South and Central America: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027  (USD Thousand)

10.5.6     South and Central America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

10.5.7     Brazil: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.5.7.1    Brazil: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.5.7.2    Brazil: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.5.7.3    Brazil: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.5.7.4    Brazil: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.5.8     Argentina: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (USD Thousand)

10.5.8.1    Argentina: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.5.8.2    Argentina: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.5.8.3    Argentina: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.5.8.4    Argentina: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

11.          Impact Of COVID-19 Pandemic On Global Exosome Diagnostic And Therapeutic Market

11.1    North America: Impact assessment of COVID-19 Pandemic

11.2    Europe: Impact assessment of COVID-19 Pandemic

11.3    Asia-Pacific: Impact assessment of COVID-19 Pandemic

11.4    Rest of World: Impact assessment of COVID-19 Pandemic

12.          Exosome Diagnostic and Treatment Market –Industry Landscape

12.1    Overview

12.2    Growth Strategies In The Exosome diagnostic and treatment Market, 2017-2020

12.3    Inorganic Growth Strategies

12.3.1     Overview

12.4    Organic Growth Strategies

12.4.1     Overview

13.          Company Profiles

13.1    Cell Guidance Systems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Bioregenerative Sciences

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Evomic Science LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Norgen Biotek Corp

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Miltenyi Biotec

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Therapeutic Solutions International, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     SWOT Analysis

13.6.5     Key Developments

13.7    Aethlon Medical, Inc

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    RENEURON GROUP PLC

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    ITH, Immune Therapy Holdings AB

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Exosome Diagnostics

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms


LIST OF TABLES

Table 1.             North America Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousands)

Table 2.             North America Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 3.             North America Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 4.             US Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 5.             US Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 6.             US Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 7.             Canada Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 8.             Canada Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 9.             Canada Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 10.          Mexico Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 11.          Mexico Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 12.          Mexico Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 13.          Europe Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousands)

Table 14.          Europe Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 15.          Europe Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 16.          Germany Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 17.          Germany Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 18.          Germany Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 19.          France Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 20.          France Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 21.          France Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 22.          UK Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 23.          UK Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 24.          UK Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 25.          Italy Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 26.          Italy Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 27.          Italy Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 28.          Spain Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 29.          Spain Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 30.          Spain Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 31.          Asia Pacific Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousands)

Table 32.          Asia Pacific Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 33.          Asia Pacific Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 34.          China Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 35.          China Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 36.          China Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 37.          Japan Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 38.          Japan Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 39.          Japan Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 40.          India Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 41.          India Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 42.          India Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 43.          South Korea Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 44.          South Korea Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 45.          South Korea Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 46.          Australia Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 47.          Australia Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 48.          Australia Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 49.          Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)

Table 50.          Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 51.          Middle East and Africa Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 52.          UAE Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 53.          UAE Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 54.          UAE Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 55.          Saudi Arabia Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 56.          Saudi Arabia Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 57.          Saudi Arabia Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 58.          South Africa Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 59.          South Africa Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 60.          South Africa Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 61.          South and Central America Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 62.          South and Central America Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 63.          South and Central America Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 64.          Brazil Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 65.          Brazil Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 66.          Brazil Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 67.          Argentina Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 68.          Argentina Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 69.          Argentina Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 70.          Recent Inorganic Growth Strategies in The Exosome Diagnostic and Treatment Market

Table 71.          Recent Organic Growth Strategies in The Exosome Diagnostic and Treatment Market

Table 72.          Glossary of Terms, Exosome diagnostic and treatment market

 


LIST OF FIGURES

Figure 1.           Exosome Diagnostic and Therapeutic Market Segmentation

Figure 2.           Exosome Diagnostic and Therapeutic Segmentation, By Region

Figure 3.           Global Exosome Diagnostic and Therapeutic Market Overview

Figure 4.           Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth during the Forecast Period

Figure 6.           Global Exosome diagnostic and therapeutic Market, By Geography (US$ Million)

Figure 7.           Global Exosome Diagnostic and Therapeutic Market- Leading Country Markets (US$ Thousand)

Figure 8.           Global Exosome Diagnostic and Therapeutic Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia pacific PEST Analysis

Figure 12.        Middle East & Africa PEST Analysis

Figure 13.        South and central America PEST Analysis

Figure 14.        Exosome diagnostic and therapeutic market impact analysis of driver and restraints

Figure 15.        Global Exosome Diagnostic and Therapeutic Market– Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Exosome Diagnostic and Therapeutic Market– By Geography Forecast And Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Exosome Diagnostic and Therapeutic Market

Figure 18.        Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

Figure 19.        Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 20.        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 21.        Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)

Figure 22.        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 23.        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 24.        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 25.        Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)

Figure 26.        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 27.        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 28.        Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 29.        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 30.        North America: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 31.        North America Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)

Figure 32.        US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 33.        Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 34.        Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 35.        Europe: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 36.        Europe Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)

Figure 37.        Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 38.        France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 39.        UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 40.        Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 41.        Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 42.        Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 43.        Asia Pacific Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)

Figure 44.        China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 45.        Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 46.        India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 47.        South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 48.        Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 49.        Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019)  (USD Thousand)

Figure 50.        Middle East and Africa Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)

Figure 51.        UAE: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 52.        Saudi Arabia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 53.        South Africa: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 54.        South and Central America: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 55.        South and Central America Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027  (USD Thousand)

Figure 56.        South and Central America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

Figure 57.        Brazil: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 58.        Argentina: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 59.        Impact Of Covid-19 Pandemic In North American Country Markets

Figure 60.        Impact Of Covid-19 Pandemic In Europe Country Markets

Figure 61.        Impact Of Covid-19 Pandemic In Asia-Pacific Country Markets

Figure 62.        Impact Of Covid-19 Pandemic In Rest Of World Country Markets

Figure 63.        Growth Strategies in the Exosome diagnostic and treatment Market, 2017-2020

The List of Companies - Exosome Diagnostic and Treatment Market

  1. Aethlon Medical, Inc
  2. Therapeutic Solutions International, Inc
  3. ReNeuron Group plc
  4. Immune Therapy Holdings AB
  5. Cell Guidance Systems LLC
  6. BioRegenerative Sciences
  7. Evomic Science LLC
  8. Norgen Biotek Corp
  9. Exosome Diagnostics, Inc./Bio-Techne
  10. Miltenyi Biotech
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the exosome diagnostic and therapeutic market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global exosome diagnostic and therapeutic market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00005514
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Exosome is nanovesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication in the cancer diagnosis. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T cells, which modifies neoplasm progression within the human body.

The factors that are driving growth of the market are greater precision and advantages over traditional methods of diagnosis and therapeutics and rise in research and development activities. Moreover, growing preference for noninvasive and novel diagnostic procedures are offering lucrative opportunities for the growth of the market.

The exosome diagnostic and therapeutic market majorly consists of the players such as Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, Norgen Biotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and Miltenyi Biotec among others.

Pricing